Featured Research

from universities, journals, and other organizations

Parasite-induced genetically driven autoimmune Chagas disease

Date:
March 29, 2011
Source:
Public Library of Science
Summary:
Researchers have shown that the Trypanosoma cruzi agent of Chagas disease invades host embryo cells and spreads its mitochondrial DNA (kDNA) minicircles into the host's genome. Scientists inoculated virulent typanosomes in fertile chicken eggs and documented the heritability and fixation of the kDNA mutations in the chicks and their progeny. The results show that kDNA-mutated chickens undergo genotype alterations, developing an inflammatory heart condition similar to Chagas disease in humans.

Researchers have shown that the Trypanosoma cruzi agent of Chagas Disease (CD) invades host embryo cells and spreads its mitochondrial DNA (kDNA) minicircles into the host's genome. Dr. Antonio Teixeira and associates at the University of Brasνlia, Brazil, inoculated virulent typanosomes in fertile chicken eggs and documented the heritability and fixation of the kDNA mutations in the chicks and their progeny. The results, published in the open-access journal PLoS Neglected Tropical Diseases on March 29th, show that kDNA-mutated chickens undergo genotype alterations, developing an inflammatory heart condition similar to Chagas disease in humans.

Chagas is one of the most lethal endemic infectious diseases in the Western Hemisphere, and although initially restricted to South America, it is now present in many parts of the world. This insect-born infection can also be transmitted from mother to child and via blood transfusion, and while acute infections are usually acquired in infancy or childhood, chronic Chagas disease kills many of those infected after they reach 40 years of age. The disease attacks the heart and is the most frequent cause of heart failure in endemic regions. While the treatment of Chagas disease with anti-trypanosomal nitroderivatives curtails the parasitic infection, it does not abrogate the destructive heart lesions which can lead to death.

An earlier study by Santos-Buch and Teixeira (1974) showed that immune lymphocytes from chagasic rabbits destroy embryo heart cells in vitro, and that this accelerated rejection of target cells occurred within 10 hours. Control, non-immune lymphocytes adhered to target heart cells 72 hours after incubation. Now, Dr Teixeira's research team describes the origin of the autoimmune rejection of the target heart cells in Chagas disease: "This chicken model was necessary to eliminate any residual active infection, because the birds are resistant to T. cruzi infection upon hatching. The kDNA-mutated chickens develop clinical signs of the heart disease and failure -- their hearts are grossly enlarged and microscopic exams reveal that immune lymphocytes adhere to the target cells and lyses."

As Dr. Teixeira explains, this is "the first time that an autoimmune disease has been experimentally reproduced in an animal model, showing specific parasite induced kDNA modifications in coding regions of the host's genome."


Story Source:

The above story is based on materials provided by Public Library of Science. Note: Materials may be edited for content and length.


Journal Reference:

  1. Antonio R. L. Teixeira, Clever Gomes, Nadjar Nitz, Alessandro O. Sousa, Rozeneide M. Alves, Maria C. Guimaro, Ciro Cordeiro, Francisco M. Bernal, Ana C. Rosa, Jiri Hejnar, Eduardo Leonardecz, Mariana M. Hecht. Trypanosoma cruzi in the Chicken Model: Chagas-Like Heart Disease in the Absence of Parasitism. PLoS Neglected Tropical Diseases, 2011; 5 (3): e1000 DOI: 10.1371/journal.pntd.0001000

Cite This Page:

Public Library of Science. "Parasite-induced genetically driven autoimmune Chagas disease." ScienceDaily. ScienceDaily, 29 March 2011. <www.sciencedaily.com/releases/2011/03/110329172243.htm>.
Public Library of Science. (2011, March 29). Parasite-induced genetically driven autoimmune Chagas disease. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2011/03/110329172243.htm
Public Library of Science. "Parasite-induced genetically driven autoimmune Chagas disease." ScienceDaily. www.sciencedaily.com/releases/2011/03/110329172243.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) — Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) — The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) — Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) — New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins